https://www.nimbustx.com | United States | 2009 | $427M
Nimbus Therapeutics is a clinical-stage, structure-based drug discovery company in the United States focusing on developing breakthrough medicines for metabolic diseases, cancer, and immune-inflammatory disorders. The company combines computational technologies and machine learning-based predictive modeling to progress small molecule drug candidates through discovery and development. Nimbus has advanced programs targeting ACC, IRAK4, and Tyk2, as well as a growing pipeline of preclinical assets for other disease-relevant targets. The company has received funding from various investors and formed collaborations to leverage its drug discovery expertise.
